Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 6.11% is 34% below its 5-year average of 9.27%, around the middle of its 5-year range (-1.98%–18.59%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.37% below its 12-month average of 8.65%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 6.11%.
RETURN ON INVESTED CAPITAL (ROIC)
6.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
8.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
9.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
9.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
2.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-29.37%
CURRENT VS 3Y AVG
-33.32%
CURRENT VS 5Y AVG
-34.15%
CURRENT VS 10Y AVG
+144.91%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 614 covered companies
CURRENT VS SECTOR MEDIAN
+118.29%
vs the sector median at left
Collegium Pharmaceutical, Inc.
Market Cap
$708.19M
Return on Invested Capital (ROIC)
6.11%
TTM Avg
8.65%
3Y Avg
9.16%
5Y Avg
9.27%
Market Cap
$707.95M
Return on Invested Capital (ROIC)
-50.92%
TTM Avg
-35.84%
3Y Avg
-41.63%
5Y Avg
-32.97%
Market Cap
$704.02M
Return on Invested Capital (ROIC)
-110.62%
TTM Avg
-99.41%
3Y Avg
-74.42%
5Y Avg
-73.36%
Market Cap
$716.10M
Return on Invested Capital (ROIC)
-12.00%
TTM Avg
-7.53%
3Y Avg
-5.45%
5Y Avg
-2.27%
Market Cap
$718.57M
Return on Invested Capital (ROIC)
-19.45%
TTM Avg
-59.05%
3Y Avg
-125.75%
5Y Avg
-106.53%
Market Cap
$692.29M
Return on Invested Capital (ROIC)
-41.63%
TTM Avg
-2189.24%
3Y Avg
-1224.39%
5Y Avg
-874.41%
Market Cap
$726.83M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-136.50%
3Y Avg
-154.74%
5Y Avg
-122.58%
Market Cap
$676.72M
Return on Invested Capital (ROIC)
-101.43%
TTM Avg
-70.16%
3Y Avg
-61.78%
5Y Avg
-52.46%
Market Cap
$666.95M
Return on Invested Capital (ROIC)
-73.27%
TTM Avg
-60.64%
3Y Avg
-63.77%
5Y Avg
-62.42%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Collegium Pharmaceutical, Inc. (COLL) | $708.19M | 6.11% | 8.65% | 9.16% | 9.27% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $707.95M | -50.92% | -35.84% | -41.63% | -32.97% |
| Faeth Therapeutics, Inc. (FTH)vs › | $704.02M | -110.62% | -99.41% | -74.42% | -73.36% |
| Cytek Biosciences, Inc. (CTKB)vs › | $716.10M | -12.00% | -7.53% | -5.45% | -2.27% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $718.57M | -19.45% | -59.05% | -125.75% | -106.53% |
| Anteris Technologies Global Corp. (AVR)vs › | $692.29M | -41.63% | -2189.24% | -1224.39% | -874.41% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $726.83M | N/A | -136.50% | -154.74% | -122.58% |
| Annexon, Inc. (ANNX)vs › | $676.72M | -101.43% | -70.16% | -61.78% | -52.46% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | -73.27% | -60.64% | -63.77% | -62.42% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $666.36M | -44.30% | -32.94% | -36.44% | -31.30% |
ROIC
6.1%
ROE
15.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 6.11% |
| 2026-03-31 | 10.51% |
| 2025-12-31 | 9.78% |
| 2025-09-30 | 9.39% |
| 2025-06-30 | 7.45% |
| 2025-03-31 | 7.93% |
| 2024-12-31 | 9.79% |
| 2024-09-30 | 10.80% |
| 2024-06-30 | 18.59% |
| 2024-03-31 | 16.18% |
| 2023-12-31 | 12.22% |
| 2023-09-30 | 7.18% |
| 2023-06-30 | 9.61% |
| 2023-03-31 | 6.90% |
| 2022-12-31 | 3.69% |
| 2022-09-30 | -1.35% |
| 2022-06-30 | -1.98% |
| 2022-03-31 | -1.40% |
| 2021-12-31 | 3.82% |
| 2021-09-30 | 12.81% |
| 2021-06-30 | 13.50% |
| 2021-03-31 | 15.37% |
| 2020-12-31 | 12.07% |
| 2020-09-30 | 8.41% |
| 2020-06-30 | 1.60% |
| 2020-03-31 | -1.99% |
| 2019-12-31 | -21.91% |
| 2019-09-30 | -9.78% |
| 2019-06-30 | -14.08% |
| 2019-03-31 | -16.11% |
| 2018-12-31 | -19.62% |
| 2018-09-30 | -13.42% |
| 2018-06-30 | -12.61% |
| 2018-03-31 | -14.68% |
| 2017-12-31 | -71.47% |
| 2017-09-30 | -86.81% |
| 2017-06-30 | -100.11% |
| 2017-03-31 | -86.26% |
| 2016-12-31 | -66.37% |
| 2016-09-30 | -95.91% |
| 2016-06-30 | -56.40% |
| 2016-03-31 | -30.38% |
| 2015-12-31 | -28.44% |
| 2015-09-30 | -20.57% |
| 2015-06-30 | -16.36% |
| 2015-03-31 | -41.36% |
| 2014-12-31 | -2037.37% |
